Carboplatin
Carboplatin is a prescription chemotherapy drug used to treat certain cancers. It's administered intravenously as an injectable solution in strengths of 50mg/5ml, 150mg/15ml, or 450mg/45ml (all at 10mg/ml). Manufactured by Hospira, Inc., it's a platinum-based medication approved under ANDA076517. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Carboplatin is a prescription chemotherapy drug used to treat certain cancers. It's administered intravenously as an injectable solution in strengths of 50mg/5ml, 150mg/15ml, or 450mg/45ml (all at 10mg/ml). Manufactured by Hospira, Inc., it's a platinum-based medication approved under ANDA076517. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Carboplatin", "mediaType": "text/html", "description": " Access the FDA dataset for Carboplatin — ANDA 205487 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205487" } ] |
| identifier | ANDA205487 |
| issued | 2016-09-16 |
| keyword |
[ "drug-manufacturers", "drug-safety", "medications", "pharmaceuticals", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Carboplatin |
